Tests for “rash + fever + sore throat”
Order targeted PCR/antigen tests first (not serologies) based on clinical features; add GAS RADT/culture to prevent rheumatic fever risk, and reserve serology for measles/rubella or EBV when PCR is unavailable or late in illness. 1, 2, 3
Step 1 — Always screen for Group A Strep (morbidity/mortality/QOL):
Step 2 — Choose viral PCR/antigen tests by syndrome cues:
- Classic viral prodrome (cough, coryza, conjunctivitis) with maculopapular rash → test for measles and rubella:
- Measles rRT-PCR on nasopharyngeal/throat swab and/or urine; if PCR unavailable/late, measles IgM. Rubella rRT-PCR or IgM per local public health protocols. (High public health impact; fastest actionable = PCR.) [Augmented by general practice and surveillance evidence; see supportive data showing PCR improves confirmation in rash illness] 4, 5
- Exudative pharyngitis, posterior cervical LAD, fatigue, rash (esp. after amoxicillin) → EBV:
- EBV VCA IgM/IgG ± EBNA (preferred) or EBV PCR if immunocompromised/severe. [General practice supported; EBV common viral pharyngitis cause per IDSA] 1
- Vesicular or varicelliform rash or painful oral lesions → HSV/VZV:
- Hand-foot-mouth or herpangina, summer/fall, ulcers → Enterovirus:
- Acute respiratory illness with sore throat during season or outbreak → multiplex respiratory PCR panel (includes influenza A/B, RSV, adenovirus, rhinovirus, common coronaviruses, SARS-CoV-2) using NP swab; prioritize when results change isolation/antivirals and reduce unnecessary antibiotics. 3
- Classic viral prodrome (cough, coryza, conjunctivitis) with maculopapular rash → test for measles and rubella:
Step 3 — When initial tests negative and rash persists, add targeted second-line tests:
- Parvovirus B19 (erythema infectiosum pattern, arthralgias, pregnancy, hemolysis) → B19V PCR or IgM. [Supportive evidence of yield in undiagnosed rash/fever cohorts] 8
- HHV-6/7 (roseola pattern, young children; HHV-7 also in adults) → multiplex PCR if strongly suspected; interpret cautiously due to latency. 9
- Adenovirus (pharyngoconjunctival fever) → NP/throat PCR. 3
Pitfalls and caveats (to protect morbidity/mortality/QOL):
- Do not use antistreptococcal antibody titers for acute pharyngitis diagnosis. 1, 2
- In adults, routine back-up culture after negative GAS RADT usually unnecessary; in children/adolescents it is required. 1
- Serologies can lag and cross-react (e.g., flaviviruses); prefer PCR early. Pair samples if using IgM/IgG. 3
- If encephalitis signs (AMS, focal deficits, seizures), urgent CSF PCR for HSV-1/2, VZV, enterovirus; start empiric acyclovir. 6, 7
Minimal order sets by presentation:
- Nonspecific rash + fever + sore throat, no vesicles, no EBV features:
- Measles-like triad (cough, coryza, conjunctivitis) with rash:
- Mononucleosis-like:
- EBV VCA IgM/IgG ± EBNA; consider CMV IgM/IgG if EBV negative. 1
- Vesicular lesions:
- Lesion PCR for HSV/VZV. 6
- Hand-foot-mouth/herpangina:
- Enterovirus PCR (throat/stool). 6
Evidence strength and rationale:
- IDSA 2012 pharyngitis guideline (most authoritative/clinically impactful) directs GAS testing strategy and underscores that clinical features alone are unreliable; avoiding missed GAS reduces rheumatic fever risk. 1, 2
- IDSA/ASM 2018 lab utilization guideline supports NP/throat PCR for respiratory viruses and adenovirus. 3
- ABN/BIA encephalitis guidelines specify HSV/VZV/enterovirus PCR dominance when CNS involvement suspected. 6, 7
- Rash-fever literature supports adding measles PCR/IgM and targeted PCR panels when measles/rubella are in the differential; PCR increases case confirmation. 4, 5
- Broad multiplex panels can improve stewardship and operational efficiency when available. 3